Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges
Eduardo Gonzalez-Ochoa,Husam A Alqaisi,Gita Bhat,Nazlin Jivraj,Stephanie Lheureux
DOI: https://doi.org/10.2147/IJWH.S366680
2022-12-28
Abstract:Eduardo Gonzalez-Ochoa, 1 Husam A Alqaisi, 1 Gita Bhat, 1 Nazlin Jivraj, 1 Stephanie Lheureux 1, 2 1 Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; 2 Department of Medicine, University of Toronto, Toronto, Ontario, Canada Correspondence: Stephanie Lheureux, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada, Tel +1 416-946-2818, Email Malignant bowel obstruction (MBO) is one of the most severe complications in patients with advanced ovarian cancer, with an estimated incidence up to 50%. Its presence is related to poor prognosis and a life expectancy measured in weeks for inoperable cases. Symptoms are usually difficult to manage and often require hospitalization, which carries a high burden on patients, caregivers and the healthcare system. Management is complex and requires a multidisciplinary approach to improve clinical outcomes. Patients with inoperable MBO are treated medically with analgesics, antiemetics, steroids and antisecretory agents. Parenteral nutrition and gut decompression with nasogastric tube, venting gastrostomy or stenting may be used as supportive therapy. Treatment decision-making is challenging and often based on clinical expertise and local policies, with lack of high-quality evidence to optimally standardize management. The present review summarizes current literature on inoperable bowel obstruction in ovarian cancer, focusing on epidemiology, prognostic factors, clinical outcomes, medical management, multidisciplinary interventions and quality of life. Keywords: bowel obstruction, inoperable, ovarian cancer, medical management, multidisciplinary Malignant bowel obstruction (MBO) represents one of the most severe complications of advanced intraabdominal and intraperitoneal malignancies. It was defined in the International Conference on MBO and Clinical Protocol Committee as (a) clinical evidence of bowel obstruction via history, physical and radiographic examination, (b) bowel obstruction beyond the ligament of Treitz, (c) intraabdominal primary cancer with incurable disease, and (d) non-intraabdominal primary cancer with clear intraperitoneal disease. 1 We conducted a narrative literature review on inoperable malignant bowel obstruction in ovarian cancer, including epidemiology, clinical outcomes, complications, medical management, multidisciplinary interventions, quality of life and healthcare cost. Search was performed through MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Embase. The search was limited to human studies and English publications, with a timeframe of 20 years (from 2002 to July 2022). Conferences, case reports, comments, editorials, letters and personal narratives were excluded. A PubMed targeted search using same criteria was conducted by one author and reviewed by another author for articles between 1980 and 2002. Epidemiology of malignant bowel obstruction is not well established; retrospective and autopsy studies have reported an incidence up to 50% in ovarian cancer and between 10 and 28% in gastrointestinal cancers. 2 It is associated with a poor prognosis, with survival estimates of 3–8 months for those with operable disease and 4–5 weeks in inoperable cases. 3,4 Obstruction may originate in the small bowel, large bowel, or in both simultaneously. MBO can be classified as partial or complete, according to the presence or absence of residual air and fluid in the collapsed distal bowel segments. 5 A closed-loop obstruction indicates a complete blockage distally and proximally in a given segment of the intestine. 6 The etiology is multifactorial and can be divided into two main groups: mechanical and functional. Mechanical causes include extrinsic obstruction due to mesenteric/omental masses or malignant adhesions, intramural, and intraluminal occlusions. Functional obstruction includes motility disorders caused by tumor infiltration of the mesentery, bowel muscle or enteric plexuses. 2 Here, we focus on malignant bowel obstruction due to ovarian cancer, where peritoneal disease frequently leads to extrinsic compression of the bowel. Pathophysiology of MBO is multifactorial. An occlusion of the lumen prevents the propulsion of the intestinal contents, causing accumulation of intestinal secretions and malabsorption of water and electrolytes in the obstructed segment. Bowel distension stimulates intestinal fluid secretion, creating a vicious cycle 7 (Figure 1). Figure 1 Pathophysiology of MBO. Occlusion of the lumen and accumulation of intestina -Abstract Truncated-